19-51646726-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001098612.3(SIGLEC14):āc.34G>Cā(p.Gly12Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000098 ( 0 hom., cov: 13)
Exomes š: 0.000025 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
SIGLEC14
NM_001098612.3 missense
NM_001098612.3 missense
Scores
5
14
Clinical Significance
Conservation
PhyloP100: 1.06
Genes affected
SIGLEC14 (HGNC:32926): (sialic acid binding Ig like lectin 14) Predicted to enable sialic acid binding activity. Predicted to be involved in cell adhesion. Predicted to be located in ficolin-1-rich granule membrane and tertiary granule membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.17231429).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SIGLEC14 | NM_001098612.3 | c.34G>C | p.Gly12Arg | missense_variant | 1/7 | ENST00000360844.7 | NP_001092082.1 | |
SIGLEC14 | XM_047437991.1 | c.34G>C | p.Gly12Arg | missense_variant | 1/5 | XP_047293947.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SIGLEC14 | ENST00000360844.7 | c.34G>C | p.Gly12Arg | missense_variant | 1/7 | 1 | NM_001098612.3 | ENSP00000354090 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 8AN: 112488Hom.: 0 Cov.: 13 FAILED QC
GnomAD3 genomes
AF:
AC:
8
AN:
112488
Hom.:
Cov.:
13
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000383 AC: 2AN: 52202Hom.: 0 AF XY: 0.0000383 AC XY: 1AN XY: 26116
GnomAD3 exomes
AF:
AC:
2
AN:
52202
Hom.:
AF XY:
AC XY:
1
AN XY:
26116
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000250 AC: 13AN: 520160Hom.: 0 Cov.: 6 AF XY: 0.0000185 AC XY: 5AN XY: 269842
GnomAD4 exome
AF:
AC:
13
AN:
520160
Hom.:
Cov.:
6
AF XY:
AC XY:
5
AN XY:
269842
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000977 AC: 11AN: 112576Hom.: 0 Cov.: 13 AF XY: 0.0000951 AC XY: 5AN XY: 52552
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
11
AN:
112576
Hom.:
Cov.:
13
AF XY:
AC XY:
5
AN XY:
52552
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 23, 2021 | The c.34G>C (p.G12R) alteration is located in exon 1 (coding exon 1) of the SIGLEC14 gene. This alteration results from a G to C substitution at nucleotide position 34, causing the glycine (G) at amino acid position 12 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
.;.;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;M
MutationTaster
Benign
N;N
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;D;D
REVEL
Benign
Sift
Uncertain
.;D;D
Sift4G
Uncertain
T;T;D
Polyphen
0.96
.;.;D
Vest4
MutPred
Loss of catalytic residue at G13 (P = 0.0931);Loss of catalytic residue at G13 (P = 0.0931);Loss of catalytic residue at G13 (P = 0.0931);
MVP
MPC
2.6
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at